Calbiotech, Inc’s Post

Excited for the 7th Alcor Drug Discovery Platform Summit under the esteemed leadership of our Chairman for Day 1, Abdulkader Rahmo, who serves as President & CSO SMSbiotech. As we convene for this premier event, we embark on a collective journey of exploration, collaboration, and innovation in the dynamic realm of drug discovery. Under Chairman Rahmo's visionary guidance, this summit promises to be a nexus of cutting-edge research, insightful discussions, and invaluable networking opportunities. Join us as we unite with leading experts, industry pioneers, and visionaries to chart the course for the future of drug discovery. This summit isn't just about presentations—it's a convergence of minds dedicated to driving progress, shaping the future, and making a meaningful impact on global health. Let's elevate the discourse, ignite innovation, and propel the field of drug discovery to new heights. Together, we're shaping a healthier, brighter tomorrow. #AlcorDrugDiscovery #Summit #Innovation #ADDP2024 #DrugDiscovery #Preclinical #LifeSciencesSummits #DrugDiscovery #PreclinicalSummits #USADrugDiscoverySummits

🎥 Exclusive Interview with Johanna Michielin during Research & Innovation Meetings hosted by Amgen France, in collaboration with Institut Pasteur and BioLabs. Our Regional Director Europe, Johanna Michielin, at BioLabs dives deeper into the role of collaboration and innovative ecosystems in accelerating breakthroughs in biomedical research. A big thank you to Amgen France and Institut Pasteur for this inspiring event and for showcasing the future of healthcare innovation. #Innovation #Amgen #InstitutPasteur #BioLabs #Collaboration #Healthcare #BiomedicalResearch" Julie Soma Quentin Bourgaud Johanna Michielin Christophe Tallec Chaimaa Asri Alessandro Ancillotti Clément Lapierre

Microbiologics Welcomes SensID! Microbiologics is excited to announce the addition of SensID, a leader in oncology and precision medicine diagnostics based in Rostock, Germany. This partnership strengthens their mission to advance global healthcare by combining SensID’s expertise with their commitment to quality control in diagnostics. Together, they will support technology developers and healthcare professionals to improve patient care worldwide. Congratulations Microbiologics, Granite Partners, Lathrop GPM LLP, and CLA (CliftonLarsonAllen), all corporate-level investors in the GSDC, for their role in this successful partnership! #HealthcareInnovation #BiotechPartnership #AdvancingHealthcare

USC announces strategic collaboration with Autobahn Labs to accelerate drug discovery! We’re thrilled to share a groundbreaking partnership between the University of Southern California and Autobahn Labs, Inc., designed to fast-track drug discovery and translational research. This collaboration brings together USC’s world-class research ecosystem with Autobahn Labs’ innovative funding model and expertise, driving therapeutic breakthroughs from bench to bedside. This initiative reflects a team-based approach to supporting innovation, spearheaded by MESH Strategic Partnerships, Keck School of Medicine of USC and the USC Stevens Center for Innovation. Together with Autobahn, we are redefining the future of drug discovery. What this means: - Empowering faculty to bring their therapeutic innovations to life - Streamlining the journey from discovery to development - Unlocking opportunities to tackle unmet medical needs We’re proud to be part of this transformative initiative and excited about the potential discoveries ahead. https://lnkd.in/gqNSWK8w For more information, contact Camilo Ansarah-Sobrinho #Innovation #DrugDiscovery #Collaborate2Innovate #USCMESH #USCStevens #AutobahnLabs #AcademicIndustryPartnerships #TranslationalResearch #USCResearch

What an exciting and energising PI Forum! How can we drive to reduce drug therapy costs and meet sustainability targets? Our industry certainly agrees that PI is in part the answer. Join the conversation! #sartorius #processintensification #innovation

We are thrilled to announce USC's partnership with Autobahn Labs, Inc. to accelerate drug discovery and transform groundbreaking research into life-saving therapies. The USC Stevens Center for Innovation, with MESH Strategic Partnerships, Keck School of Medicine of USC, is proud to help bridge academic breakthroughs with industry expertise, advancing treatments for critical unmet medical needs. Together, we’re paving the way for impactful healthcare innovation. #USC #DrugDiscovery #Innovation #USCStevens #USCMESH

𝗝𝗣 𝗠𝗼𝗿𝗴𝗮𝗻 𝟮𝟬𝟮𝟱 𝗦𝗽𝗲𝗰𝗶𝗮𝗹 – 𝗗𝗲𝗮𝗹𝗠𝗮𝗸𝗲𝗿 𝗼𝗳 𝘁𝗵𝗲 𝗬𝗲𝗮𝗿 𝟮𝟬𝟮𝟰 (Part 2) Our Part 2 of the DealMaker of the Year is out (based on TDV) 🎉 In partnership with DealForma, Octavus Consulting are thrilled to announce the DealMaker of the Year 2024 – Novo Nordisk! 🏆 Novo Nordisk secured the title with an impressive 𝟮𝟰 𝗱𝗲𝗮𝗹𝘀 (vs. 21 in 2023) worth approximately $𝟯𝟯.𝟬𝟵𝗕𝗻. 📌 Key Highlights: 1. 𝗧𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰 𝗙𝗼𝗰𝘂𝘀: Endocrine & Metabolic Disorders remain the cornerstone for Novo Nordisk, with a total of 7 deals worth $2.29Bn. 2. 𝗡𝗼𝘁𝗮𝗯𝗹𝗲 𝗗𝗲𝗮𝗹: Novo Nordisk led the list with a significant deal involving Catalent Pharma Solutions, valued at ~$16.5Bn. Did you miss 𝗝𝗣 𝗠𝗼𝗿𝗴𝗮𝗻 𝟮𝟬𝟮𝟱? A wealth of data and insights were shared during JP Morgan 2025, including strategic directions and major deals. But don’t worry, Team @Octavus has you covered! 📥 Register here for tailored J.P. Morgan 2025 coverage, and our team will reach out with a quote: https://lnkd.in/g7nGu4yy 📊 What stands out the most to you in this dashboard? Share your thoughts in the comments below! 💼 What’s more? If you’d like early access to our detailed report (in PDF format): https://lnkd.in/gn5viqva Want to talk to us? 𝗕𝗹𝗼𝗰𝗸 𝘆𝗼𝘂𝗿 𝗰𝗮𝗹𝗲𝗻𝗱𝗮𝗿 here: https://lnkd.in/g3DSV3Fy Or do you want insights into Novo Nordisk’s 2024 deals data? 📩 Drop us an email at connect@pharmashots.com with the subject line: JPM 2025 Dealmaker - Novo Nordisk (Business Email Only). Let’s kickstart 2025 with innovation, insights, and collaboration at #JPM2025 #PharmaShots #NovoNordisk #DealForma #PharmaDeals #BiopharmaInnovation #HealthcareLeadership! 🚀

Explore the scientific and operational elegance behind study replication with real-world #EHRdata in an upcoming webinar, hosted by OM1 and Panalgo experts, covering: ✅ #Vitiligo and #alopeciaareata landscapes including prevalence, current treatment options, treatments in development, co-occurrence of the two conditions, and impact on patients’ quality of life. ✅ Study replication and treatment pathway visualization in Panalgo’s IHD platform. ✅ Richness of OM1 and multi-modal data. 📍Register here: https://hubs.ly/Q02xNSvM0

Use Medical Claims to study how your drug or device is used in the real-world? See how easily a claims analysis can be replicated use EHR-based data on a joint webinar using OM1, Inc.'s RWD from EHRs and Panalgo's IHD analytics platform. Listen to the experts: Kathryn Starzyk, Margaret (Meg) Richards, PhD, MPH, and Michael Munsell, PhD #RWD #outcomes #analytics